US Stocks
/
Dianthus Therapeutics, Inc. Share Price
Dianthus Therapeutics, Inc. Share Price

Dianthus Therapeutics, Inc. Share Price

NASDAQ: DNTH | Mid Cap
$82.39
-$2.62 (-3.08%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Dianthus Therapeutics, Inc. Stock Performance

Open
$84.23
Prev. Close
$85.01
Circuit Range
N/A
Day Range
$81.20 - $84.64
Year Range
$32.40 - $117.78
Volume
83,895
Average Traded
$82.49

Dianthus Therapeutics, Inc. Share Price Today

As of 9 October 2026, Dianthus Therapeutics, Inc.'s share price is $82.39. The stock opened at $84.23, compared to its previous close of $85.01. During today's trading session, Dianthus Therapeutics, Inc.'s share price traded between $81.20 and $84.64, with an average price of $82.92. Over the past 52 weeks, the stock has recorded a high of $117.78 and a low of $32.40. In terms of performance, Dianthus Therapeutics, Inc.'s share price has declined by 6.20% over the last six months and is up 135.67% on a year-on-year basis.

Dianthus Therapeutics, Inc. Share Price Chart

$81.20$84.64
L
Show Current Price
H

Dianthus Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.18B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.44
Revenue (TTM)
$2.04B
Return On Equity (TTM)
-16.40%
Profit Margin
-7957.84%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-36.58%

Dianthus Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.40$0.28$0.46$0.76
Net Profit-$36.77-$64.43-$40.83-$50.22
Net Profit Margin-9192.50%-23010.71%-8876.09%-6607.89%
Income ChangeN/A-75.22%36.63%-23.00%

Dianthus Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$2.83$6.24$2.04
Net Profit-$43.56-$84.97-$162.34
Net Profit Margin-1539.22%-1361.70%-7957.84%
Income ChangeN/A-95.06%-91.06%

About Dianthus Therapeutics, Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Dianthus Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$89.04
$82.33
-6.60%
Sep 2026
$105.55
$88.14
-20.93%
Aug 2026
$104.56
$111.48
+4.26%
Jul 2026
$96.93
$106.92
+9.69%
Jun 2026
$91.78
$97.47
+4.86%
May 2026
$89.30
$92.96
+5.83%
Apr 2026
$86.57
$87.84
+4.73%
Mar 2026
$53.84
$83.87
+52.10%
Feb 2026
$52.94
$55.14
+3.15%
Jan 2026
$41.00
$53.45
+29.71%
Dec 2025
$43.50
$41.21
-6.26%
Nov 2025
$34.91
$43.96
+25.74%

DNTH Share Price FAQs

What is Dianthus Therapeutics, Inc. share price today?

chevron-up
Dianthus Therapeutics, Inc. share price today is $82.39 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Dianthus Therapeutics, Inc. stock?

chevron-up
The 52 week high of Dianthus Therapeutics, Inc. stock is $117.78, while the 52 week low is $32.40 as of 9 Oct '26.

What is DNTH's market capitalisation today?

chevron-up
DNTH market capitalisation is $3.18B as of October 9, 2026, at 4:45 pm IST.

What is DNTH's net income for the last quarter?

chevron-up
DNTH's net income for the last quarter is -50.22B USD.

What is the 5 year returns of DNTH?

chevron-up
The 5 year returns of DNTH is -19.54% as on 9 Oct '26.

What is the high & low stock price of DNTH today?

chevron-up
DNTH stock price hit a high of $84.64 and low of $81.20 as of 9 Oct '26.

Can I buy DNTH shares in India?

chevron-up
Yes. You can buy DNTH in India by opening an international trading account.